Investigators at Amavita Research.

Senior principal investigator and interventional cardiologist with a structural-heart (TAVR) research background. National Principal Investigator (chair) of the PROTECT II trial; Steering Committee member for PROTECT IV; Principal Investigator at Henry Ford for the PARTNER trial. Founder of the National Cardiogenic Shock Initiative. 45+ years of cardiovascular medicine experience.

• Wikidata profile

Harvard-trained, board-certified interventional cardiologist (since 2009) and investigator on 30+ clinical trials and registries, 6 of them ongoing. Worldwide Principal Investigator on the Percutaneous Mitral Valve Annuloplasty trial. ABIM Board Certified and IAOCR-Qualified Investigator (QM-IAOCR, Reg. 9851511). Voluntary Assistant Professor at the University of Miami Miller School of Medicine. Founder of amavita Heart and Vascular Health®, independent Miami cardiovascular practice; 16,000+ patients seen in the last 3 years, and Site Director for SOP SITE-107 site-performance reviews.

• Wikidata profile

Board-certified electrophysiologist with 9+ years of practice. MD from New York University School of Medicine; internal medicine residency at Beth Israel Deaconess / Harvard Medical School; cardiovascular and clinical cardiac electrophysiology fellowships at Boston Medical Center / Boston University School of Medicine. Triple board-certified by the American Boards of Internal Medicine, Cardiovascular Disease, and Clinical Cardiac Electrophysiology, with the National Board of Echocardiography. Clinical Assistant Professor at Nova Southeastern University since 2020 and electrophysiologist at Heart Rhythm Specialists of South Florida since 2016. Joined Amavita Research Services in February 2026 as Principal/Sub-Investigator on AnaCardio AC01-02 and other arrhythmia and device trials.

Drives growth strategy, sponsor relationships, and cross-border trial operations at Amavita Research. CEO of bioaccess® with 20+ years scaling clinical research operations across the Americas. Former Ambassador of IAOCR / GCSA Americas. Accountable owner for Amavita Research's IAOCR GCSA workforce-quality and patient-engagement commitments through 2026.

• Personal site
• LinkedIn

Chief Operating Officer (COO) and Senior Clinical Research Coordinator at Amavita Research. Works closely with Lead Investigator Dr. Pedro Martinez-Clark across 27 sponsor-initiated and industry-sponsored Phase 2 and Phase 3 trials spanning heart failure, coronary artery disease, peripheral artery disease, hypertension, and acute coronary syndrome. Bilingual English / Spanish.

Florida-licensed Advanced Practice Registered Nurse (APRN #9443547), Family Nurse Practitioner from the Universidad de Turabo (Puerto Rico, 2018), AANP-certified, and Florida-licensed RN since 2016. Bilingual (English / Spanish). Sub-Investigator on Amavita's active cardiovascular protocols, working closely with Dr. Pedro Martinez-Clark. Owns patient screening and informed consent, source data verification, sponsor monitor visit support, and visit-window adherence on the active portfolio.

Florida-licensed Advanced Practice Registered Nurse (APRN #9442363), Family Nurse Practitioner from the Universidad de Turabo (Puerto Rico, 2018, 3.92 GPA), and Florida-licensed RN since 2016. Bilingual (English / Spanish). Sub-Investigator on Amavita's interventional cardiovascular protocols, working closely with Dr. Pedro Martinez-Clark. Supports cath-lab study conduct, procedural-visit coordination, post-procedure follow-up, and informed consent.

Board-certified Cardiovascular Physician Assistant with a Colombian medical degree (Universidad San Martin, Bogota, 2007) and 14+ years of research and clinical experience across the University of Miami Miller School of Medicine and Amavita Health. Trilingual in English, Spanish, and Portuguese. Co-author on peer-reviewed cardiovascular research (American Journal of Kidney Diseases, 2019).

NCCPA-Certified Physician Assistant (PA-C) and Florida-licensed Cardiovascular Physician Assistant at amavita Heart and Vascular Health® since 2023. MMS with Honors from Saint Francis University, Loretto, PA (2022); Bachelor in Physician Assistant Studies with Honors from Miami Dade College (2020); also a Foreign Medical Doctor (Universidad del Valle, Cali, Colombia, 2004). Bilingual in English and Spanish. Interprets 2D echocardiograms, stress tests, cardiac monitors, and vascular studies, and coordinates patient evaluations and care plans. Joins Amavita Research as Sub-Investigator on cardiovascular protocols.

• LinkedIn

Adidley Garcia coordinates clinical study operations at Amavita Research as Site Coordinator and Research Nurse, supporting trial conduct, participant care, and ICH-GCP E6 (R3) compliance at our Miami site.

International medical graduate (Universidad del Rosario, Bogotá, Colombia, 2019, GPA 4.23) with focused experience in cardiovascular research coordination, medical education, and clinical quality. Director of Clinical Education and Quality at amavita Heart & Vascular and CardioElite™ since 2024; previously Research Coordinator at amavita Heart & Vascular (2022–2024), where he coordinated cardiovascular research operations including patient identification, data collection, protocol support, and cross-team coordination. Supports Amavita Research with clinical education for advanced-practice providers, documentation standards, workflow standardization, and quality oversight across cardiology trial workflows. Spanish native, English professional fluency.

• LinkedIn